Bio­gen se­cures $1.5B loan to fund Rea­ta buy­out, with three-year re­pay­ment sched­ule baked in

Bio­gen has lined up a $1.5 bil­lion term loan to fund its $7.3 bil­lion ac­qui­si­tion of Rea­ta Phar­ma­ceu­ti­cals.

The com­pa­ny had made clear its in­ten­tions to fi­nance the ac­qui­si­tion with both cash and debt in its Au­gust an­nounce­ment. The loan, for which JP­Mor­gan Chase Bank act­ed as the ad­min­is­tra­tive agent, sets up two dif­fer­ent tranch­es so that Bio­gen may re­pay half of the loan with­in a year and the oth­er half with­in three years, ac­cord­ing to an SEC fil­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER